Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Repurposing of licensed therapeutic agents to treat human viral infections

June 6, 2014

Data from three phase I studies of QGE-031 reported

June 6, 2014

DuoGel designed for vaginal and rectal delivery of anti-HIV microbicides

June 6, 2014

ASP-2215, a dual receptor tyrosine kinase inhibitor for the treatment of leukemia

June 5, 2014

First-in-human phase I study of RO-5520985 for advanced solid tumors

June 5, 2014

Fixed-dose combinations of tiotropium and olodaterol compared to current monotherapies

June 5, 2014

Mouse papillomavirus model developed for testing antiviral responses

June 5, 2014

Clinical trial data presented for benralizumab as a treatment for asthma, COPD

June 5, 2014

Novel PI3Kdelta inhibitor demonstrates clinical efficacy for hematologic malignancies

June 4, 2014

Preliminary findings reported for anti-CD37 ADC in patients with NHL

June 4, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...